PROVIDER PROFILE · NPI 1881614873

Neil ShahMD

Hematology-OncologyLos Angeles, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

110

Unique beneficiaries

—

Total services

249

Distinct HCPCS

Medicare payment

$18K

Peer benchmark

Total Medicare services vs. 957 Hematology-Oncology providers in CA — below median (cohort median 4,173).

PRESCRIBING · PART D · 2024

Total Rx claims

390

Beneficiaries

—

Total drug cost

$4.2M

Distinct drugs

Brand share

94.6%

Top prescribed drugs

Dasatinib204 claims

Asciminib Hydrochloride121 claims

Bosutinib24 claims

Hydroxyurea21 claims

Nilotinib Hcl20 claims

QUALITY · MIPS · 2024

Final MIPS score

87.0

Quality

86.8

Cost

70.5

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.51%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history